Top member reports
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Risks
Added 3 months ago

No idea what is going on here.

Sensor site says they've sold to ABiomed, ABiomed says they are being acquired by Johnson & Johnson...

No news anywhere accessible to me that would give an indication as to how I can reclaim my small parcel of funds invested in this "business"

38da28f602152e552fe3386f04a54527cd96b7.pngc86edc1d1434534cafb6197e3f067693016d8e.png

Read More
#AGM
Added 4 months ago

Worth flagging on here that there is an AGM at 10:30am Melbourne time on Wednesday 9 November 2022. They note very little about anything other than going through some financial reports and re-electing some directors.


Would be great to pester them about what is keeping the company suspended from trading as I've been unfortunately tied up in this company with no way out since May 2022 and would probably like to rinse my hands and move on. Perhaps this re-elected director can buy my shares on a pink sheet.

Read More
#ASX Announcements
stale
Added 7 months ago

Back in May, Sensera was told they aren't showing enough evidence that their listing on the ASX is warranted. Fair enough.

So from my surface level reading it seems the stock is suspended indefinitely (or such time they can act in accordance to 12.1 blah blah blah....)

But a couple of days after that announcement I noticed that Capital H Management added another 20% to their holding. Interested by this as I know Harley Grosser has a good eye for smaller companies. Nothing crazy, just worth noting.

Read More
#ASX Announcements
stale
Added one year ago

@Nerdag, thanks for your Straw. 

I think the announcement highlights profitability and scalability issues. They have churned through cash once again with customer receipts far too low for my liking. I forecasted that this quarterly would be positive, with all signs pointing to ramped up production for Abiomed. I was wrong - revenue went backwards! 

Given cash burn rates, a capital raise is once again around the corner. Can you imagine the discount the company will have to offer potential investors to attract interest and raise enough capital? I am not sticking around to find out. 

This was always a speculative move on my behalf, but the turnaround hasn't occured - in fact business operations have declined - and with NanoDX pulling the pin, the risk far outweighs the reward in my opinion. 

DISC - SOLD 

Read More
Valuation of $0.125
stale
Added 2 years ago
A speculative bull case ... This MEMs ( MicroElectroMechanical System ) and Microdevices business with a core competence on microfluidics, based in the USA, has been through a rough patch and has been close to going under, however things could be about to turn around. They have enough cash to last 2 more quarters, and access to a $2M loan to see them through another 12 - 18 months. Their foundation customer, AbioMed, is back up and running after a tough time in 2020 due to Covid restrictions. Sensera have increased supply of sensors 4 fold for their Impella Heart Pump. The next customer off the rank is Nova BioMedical who are about to launch a Continuous Glucose Monitor using our sensors in a JV with LifeScan , the OneTouch CGM. Sensera should be reporting production numbers for the launch of the CGM in this quarterly. These 2 customers should see them close to cash positive by years end. The next cab off the rank, and possibly a company maker, is NanoDX with their Covid19 and TBI real time point of care solution. If this gets to market the indicative first order is $10M for this $16M MC business. On top of this, the Biden Administration is throwing $50B directly at the semi-conductor industry in the USA, with a particular focus on small, innovative CHIP companies. Sensera seems to represent a bullseye target for this funding, although only speculation on my part, I would not be surprised to see funding in the next 6 months.
Read More
#Leadership Transitions 22/2/21
stale
Added 2 years ago

Sensera Limited (Sensera) (ASX:SE1) is announcing the consolidation of management responsibilities in the company to streamline the leadership group and reduce costs. Ralph Schmitt the Managing Director has transitioned to an Executive Director role on the board. Tim Stucchi has been promoted to Chief Operating Officer (COO). Tim has been operating as the General Manager of the MicroDevices business since Sensera’s IPO and has been responsible for the day-to-day business activities.

Mr. Schmitt will continue to operate in an active leadership role and partner with Mr. Stucchi in his expanded responsibilities. Since the sale of the IOT Solutions business, Sensera has become more strategically focused on developing Micro Electro Mechanical Systems (MEMS) based sensors. Tim has been running MEMS based manufacturing businesses for over two decades and is well suited to continue the progression of Sensera’s business to a high-volume manufacturing company. For over a decade Mr. Stucchi was CEO of Advanced MicroSensors and built the business to shipping over 100 million sensors. He has extensive MEMS manufacturing background and has worked with numerous companies as a consultant including Sensera’s fab partner Agiltron, making him uniquely qualified to lead the company.

Renumeration for Mr. Schmitt will change from an employee based annualized US$300,000 base salary plus bonus and other employee benefits, to a fixed fee of US$10,000 per month.

DISC: I hold

View Attachment

Read More
Valuation of $0.060
stale
Added 3 years ago
- Won't have to raise as much cash as the share price implies - IOTS business travelling beautifully - Market fixated on a quarterly hiccup - Altor now calling the shots - Lowball value here
Read More